Download Files:
Atezolizumab
Price range: 366 CAD through 4,795 CAD
Products Details
Product Description
– Atezolizumab is an antibody inhibitor, a humanized monoclonal antibody, IgG1, which targets PD-L1 and blocks the interaction of PD-L1 with PD-1. Atezolizumab has antitumor activity and promotes T-cells to attack tumor cells.
Web ID
– T9902
Storage Temperature
– -20℃
Shipping
– Blue Ice
Citations
– 1. Chen Z, Wu Z, Wu M, et al.LncRNA SNHG16 Drives PD-L1-Mediated Immune Escape in Colorectal Cancer through Regulating miR-324-3p/ELK4 Signaling.Biochemical Genetics.2024: 1-20.
2. Di Donato M, Cristiani C M, Capone M, et al.Role of the androgen receptor in melanoma aggressiveness.Cell Death & Disease.2025, 16(1): 34.
References
– Inman BA, et al. Atezolizumab: A PD-L1-Blocking Antibody for Bladder Cancer. Clin Cancer Res. 2017 Apr 15;23(8):1886-1890.
CAS Number
– 1380723-44-3
Molecular Weight
Compound Purity
– 99.3% （SEC-HPLC）
Pathway
– Apoptosis|||Autophagy|||Cell Cycle/Checkpoint|||Immunology/Inflammation
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
1000 in stock
